Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 2008, p. 1888-1890, Vol. 52, No. 5
0066-4804/08/$08.00+0 doi:10.1128/AAC.00035-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Departments of Medical Laboratory Science and Biotechnology,1 Biochemistry and Molecular Biology,2 Pathology,3 Institute of Basic Medical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan4
Received 9 January 2008/ Returned for modification 13 February 2008/ Accepted 18 February 2008
Of 1,994 group B streptococcal isolates collected, 26 (1.3%) of the isolates were resistant to levofloxacin, and cross-resistance to other fluoroquinolones was observed. The emergence and prevalence of high-level fluoroquinolone resistance in genetically unrelated isolates were linked to the presence of gyrA, parC, and parE triple mutations in each isolate.
Published ahead of print on 25 February 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»